Team reviewing study results at a submission milestone

All stories

By program and engagement type

Oncology

Biostatistics and clinical operations moving at the pace of enrollment, with frequent protocol amendments and a tight DSMB interim analysis timeline.

Rare Disease

A small-sample analysis plan and close site contact protected data integrity across a small, geographically dispersed patient population.

Data Management at Scale

Standardized intake and a disciplined query cycle kept data cleaning ahead of high-volume, multi-vendor enrollment.

FSP Engagement

Embedded biostatistics and programming capacity that scaled with study volume, without a second full-service vendor relationship.

Want to talk through a similar situation?

Tell us about your study and we'll point you to the team that fits.